Portfolio company
VERITACELL
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company produces surgical kits for point-of-care skin cell isolation and regeneration to help surgeons and hospitals treat patient wounds and scarring.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Besthealth4u
This company develops bio-based medical adhesives and wearable sensor patches for wound care and medical device manufacturers to prevent skin injuries and monitor healing.
TYBR Health
This company develops a hydrogel system for orthopaedic surgeons to protect tendons and ligaments from internal scarring following surgical procedures.
AdipoSeeds
This biotech company develops adipose-derived mesenchymal stem cell platelets for regenerative medicine treatments and blood transfusion substitutes to assist healthcare providers and patients.
Aurealis Pharma
This company develops cell and gene therapies for patients suffering from chronic wounds, cancer and inflammatory diseases.
GeniPhys
This company develops polymerisable collagen scaffolds for tissue restoration and wound management for medical patients and healthcare providers.
VascVersa Ltd
This company develops vascular cell therapies to regenerate blood vessels for patients with ischaemic diseases, chronic wounds, and retinal vascular conditions.
PRINTYMED
This company produces biomimetic spider silk materials for medical researchers, healthcare providers, and cosmetic manufacturers to enable regenerative treatments and sustainable product formulations.
NeoSurgical
The company develops laparoscopic instruments for surgeons to close port site incisions after abdominal surgery.
